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The rationale for developing a vaccine for schistosomiasis, a disease affecting 
200-300 million people worldwide, is based on observations that infected labo- 
ratory animals can develop resistance to challenge infections. For instance, in the 
mouse model of schistosomiasis,  immunity to  challenge  infection  is  normally 
acquired by animals harboring adult worms (1,  2). Although resistance can be 
seen in mice harboring either unisexual or bisexual adult worms (3), mice with 
worms of one sex usually exhibit low levels of resistance to challenge (4,  5) as 
compared with mice having patent infections with organisms of both sexes. 
Because bisexually infected mice develop high levels of resistance to challenge 
6-8 wk after the primary infection (6) and female worms begin laying eggs ~5 
wk postinfection, egg production has been linked to high levels of resistance. 
In investigations of the putative link between egg production and immunity, 
immunization with isolated eggs or egg extracts has, in general, failed to dem- 
onstrate any protective effect (5, 7-I0) although one study by Moore et al. (1 I) 
did demonstrate low levels of resistance to challenge in mice that were immunized 
with eggs or egg extract.  Moreover, in experiments where immunization with 
eggs  resulted  in  significant  resistance  to  challenge,  the  protective  effect  was 
ascribed to the granulomatous response to eggs in the tissues, which was thought 
to kill or damage migrating parasites nonspecifically (6, 9, 12). 
Thus, the data available are ambiguous as to the role of the egg in naturally 
acquired resistance. For this reason, we began production of lymphocyte hybri- 
domas secreting monoclonal antibodies to egg antigens to find out if eggs or egg 
antigens could induce protective antibodies. 
We report here the production of anti-egg monoclonal antibodies that recog- 
nize antigenic determinants on the surface membranes of developing schistoso- 
mula.  We  also  show  that  these  anti-egg  monocional  antibodies  are  partially 
protective  against  challenge  infection,  demonstrated  by  the  in  vivo  passive 
transfer of immunity. 
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Materials and  Methods 
Mice.  CBA/J, BALB/c, and C57BL/6 mice were purchased from The Jackson Labo- 
ratory, Bar Harbor, ME. 
Parasites.  A Puerto Rican strain ofSchistosoma mansoni was maintained in our laboratory 
using Biomphalaria glabrata snails and CBA/J mice. Schistosoma japonicum- and S. haemato- 
bium-infected snails were obtained from Dr.  Liang at the  University of Lowell, Lowell, 
MA. 
Skin  schistosomula were prepared  by allowing cercariae  to penetrate  rat abdominal 
skin, as described by Clegg and Smithers (13). In addition, schistosomula were prepared 
mechanically (I4)  using  a  vortex  mixer in  the  case of cercariae of S.  mansoni  and  S. 
haematobium or  by passage of cercariae  through  a  23-gauge  needle  for S. japonicum. 
Parasite bodies were separated from tails by centrifugation on a Percoll (Pharmacia Fine 
Chemical, Piscataway, N  J) gradient, as was described by Lazdins et al. (15). 
Lung worms were prepared as follows: mice (C57BL/6) were infected with ~10,000 
mechanical schistosomula by tail vein injection. 4 d later, the lungs were removed and the 
lung chop assay was performed as described by Sher et al. (16), except that the lungs were 
not perfused before removal from the mouse. 
Eggs were collected from the  livers of mice infected for 8  wk with S.  mansoni. The 
infected livers in 0.225 M saline were homogenized in a Waring blender. The homogenate 
was partially cleared by sedimenting and decanting, as was described by Coker and von 
Lichtenberg (17).  Eggs were separated from contaminating liver tissue by centrifugation 
through a mixture of 40% Percoll in 0.225 M saline. The purified eggs were washed free 
of Percoll and resuspended in assay medium (minimum essential medium containing 20 
mM Hepes and 2 mM L-glutamine, pH 7.4). Soluble egg antigen (SEA) l was prepared by 
homogenizing purified eggs in phosphate-buffered saline (PBS),  pH 7.4, at 4°C for 1 h. 
The egg homogenate was centrifuged at 15,000 g for 60 rain at 4°C and the supernatant 
was collected as SEA and stored at -70°C.  Microfilaria of Brugia  malayi were prepared 
by Dr.  Louis  Lamontagne and  Dr.  W.  Piessens of the  Department of Tropical  Public 
Health at the Harvard School of Public Health. 
Infected and Normal Mouse Sera.  Female C57BL/6 mice were infected percutaneously 
with  ~50  cercariae.  Infected  mice  were  bled  at  weekly  intervals,  starting  at  12  wk 
postinfection. Sera for passive transfer of immunity experiments were collected from mice 
infected beween 12 and  16 wk and pooled. Normal mouse sera were obtained from age- 
and  sex-matched  C57BL/6  mice.  Myeloma IgG2b (Litton  Bionetics  Inc.,  Kensington, 
MD) was used as a control in some experiments. 
Production of Monoclonal Antibodies.  BALB/c  mice  were primed  by intravenous  (tail 
vein) injection of ~ 1,000 purified schistosome eggs. For one fusion, a group of mice were 
boosted in a manner identical to the way they were primed. A second fusion was done in 
which mice were boosted intravenously with  100 t~g of SEA.  In both cases, mice were 
sacrificed and their spleens were removed 4 d after the boost. The fusion protocol was 
according to Kennett et al. (18), using NS-1  cells as the myeloma line and polyethylene 
glycol 1000 as the fusing agent. Hybridomas positive for surface binding were cloned by 
limiting dilution using irradiated spleen cells as a feeder layer. Cloned hybridomas were 
maintained in culture, and culture supernatant was the source of monoclonal antibody 
for all experiments. In experiments where concentrated culture supernatants were used, 
concentration was by ultrafiltration using an Amicon YM-10 membrane (Amicon Corp., 
Danvers, MA). Antibody concentration was determined by quantitative rocket immunoe- 
lectrophoresis (19). 
Monoclonal antibody EG 1C4B 1 (E. 1), an IgG2b, was purified from culture supernatants 
by protein A  chromatography as described by Ey et al. (20).  Purified E. 1 was dialyzed 
against 400 vol of PBS,  pH 7.4,  overnight at 4°C. The pure monoclonal antibody was 
next concentrated to 2 mg protein/ml by Amicon ultrafiltration.  Protein concentration 
was determined by Bradford assay (21).  Fab fragments of E. 1 were prepared by papain 
1 Abbreviations used in this paper:  DMEM,  Dulbecco's modified Eagle's medium; ELISA, enzyme- 
linked immunosorbent assay; FCS, fetal calf serum; PBS, phosphate-buffered  saline; SEA, soluble 
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digestion according to the method of Dresser (22). Fab fragments were purified from Fc 
and undigested antibody by protein A chromatography, and the purity of the Fab fraction 
was confirmed by sodium dodecyl suifate-polyacrylamide gel electrophoresis (SDS-PAGE) 
(23). 
lsotype Analysis.  Culture supernatants from cloned hybrids were assayed for immuno- 
globulin isotype using the immunoglobulin subtype enzyme-linked immunosorbent assay 
(ELISA) assay (Boehringer Mannheim Biochemicais, Indianapolis, IN). 
Detection of Surface Binding Monoclonal Antibodies.  Living, skin-transformed schistoso- 
mula and  purified cercarial tails  were  used  in all  of the  indirect  immunofluorescence 
assays. Schistosomula were cultured  in  Dulbecco's modified Eagle's medium (DMEM) 
containing 4.5 g glucose/ml and supplemented with 5% heat-inactivated fetal calf serum 
(FCS),  100 #g]ml penicillin, and 100 t~g/ml streptomycin. Cultures of schistosomula at a 
concentration of 2,500 per milliliter were maintained in a humidified atmosphere in 7.0% 
CO2 at 37°C. 
For the fluorescence assay, schistosomula and cercarial tails were washed separately in 
assay  medium  (minimum  essential  medium  containing  20  mM  Hepes  and  penicillin] 
streptomycin with no FCS, pH 7.4), then resuspended in assay medium at a concentration 
of 2,000  per milliliter.  Approximately 200  schistosomula plus  200  cercarial tails  were 
delivered into  wells of a  96-well V-bottomed microtiter plate (Dynatech Laboratories, 
Alexandria, VA). Then an equal volume of undiluted hybridoma culture supernatant or 
control (infected or normal mouse) serum diluted  1:40 in assay medium was added. The 
plates  were  incubated  for  45  rain  at  room  temperature,  then  washed  four  times  by 
aspiration and centrifugation using a Dynatech miniwash to aspirate and refill the wells 
with assay medium. Rabbit anti-mouse IgG (Cappel Laboratories, Cochranville, PA) was 
diluted  1:100 in assay medium and added to each well for 30 min at 4°C. After washing 
four times, fluorescein-conjugated goat anti-rabbit IgG (Boehringer Mannheim Biochem- 
icals), diluted  1:100 in assay medium, was added to each well for 30 min at 4 o  C. Parasites 
were washed four times and then examined using a Leitz fluorescent microscope. 
In Vitro Complement-mediated Killing Assay.  Schistosomula obtained after skin penetra- 
tion (3-h skin schistosomula) were used in these experiments. Before culture, the schisto- 
somula were washed in assay medium and resuspended in DMEM containing 2.0% FCS, 
10%  NCTC  109,  2  mM L-glutamine, and penicillin/streptomycin as an antibiotic.  Ap- 
proximately 150 schistosomula per well were delivered into a Linbro 96-well flat-bottomed 
plate (Linbro Chemical Co.,  Hamden, CT).  Then,  each well received either  100  t~l of 
undiluted  hybridoma culture  supernatant or  100  tA of infected or normal mouse sera 
diluted  1:10.  Parasites were incubated for 30 min followed by the addition of fresh or 
heat-inactivated guinea pig sera. Cultures were kept in a humidified atmosphere at 37°C 
with 7.0% CO2. Damage to the tegument of the parasites was scored by examination with 
a  microscope. Death of parasites was assessed microscopically by toluidine blue uptake 
and loss of motility. 
In Vivo Passive Transfer: Lung Assay.  In these experiments, hybridoma culture super- 
natants were used at  1×  and  5×  concentrations.  Controls were normal mouse sera or 
infected mouse sera diluted  1:40 in DMEM plus  15%  FCS.  10-wk-old female C57BL/6 
mice were given 1.5  ml culture supernatant or control sera by intraperitoneal injection 
24  h  before challenge.  Mice  were  challenged  with  ~500  skin  schistosomula given  by 
intravenous tail vein injection. 4 d later, the mice were sacrificed, lungs removed, and the 
lung chop assay was performed as described by Sher et al. (16). The percentage reduction 
in recoverable worms was calculated as [(A -  B)/A] ×  100, where A is the mean of the 
control group and B is the mean of the experimental group. 
In Vivo Passive Transfer of Immunity: Adult Worm Assay.  As in the lung assay, culture 
supernatants were the source of monoclonal antibody in all experiments. In experiments 
where concentrated culture supernatants were used, they were concentrated as described 
above.  Control  sera  are  as  described  for  the  lung  assay.  A  myeloma IgG2b  (Litton 
Bionetics, Inc.) was used as an additional control in most experiments. 
Monoclonal antibody E. 1 and control sera were administered by intraperitoneal injec- 
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challenged with cercariae (100-180  per mouse depending on the experiment) by belly 
penetration.  Adult  worms  were  collected  6-8  wk  postchallenge  by  mesenteric  vein 
perfusion (24,  25). Livers were also squashed and examined for worms. The percentage 
reduction of adult worms was calculated as described for the lung assay. The significance 
of the differences between control and experimental groups was calculated using the 
Student's t test. 
Western Blot Analysis of Antigens.  Molecular weights of egg and schistosomula antigens 
recognized by anti-egg monoclonai antibodies were determined by Western blot (26). For 
this analysis,  we used soluble egg antigen and a detergent extract of whole mechanical 
schistosomula, which enriched for surface membrane components. Soluble egg antigen 
was prepared as described for egg purification; however, the following protease inhibitors 
were added before homogenization: chymostatin (4 mM), leupeptin (4 mM), aprotinin 
(0.03%),  phenylmethylsulfonyl  fluoride (2 mM), N-a-p-tosyi-L-lysine chioromethyl ketone 
HCI  (TLCK) (0.2  mM),  and  L(tosylamide-2-phenyl)ethyl-chloromethyl-ketone  (TPCK) 
(0.2 mM). 
Surface extract of schistosomula was prepared by incubating mechanical schistosomula 
(cultured for 3 h) in 50 mM phosphate buffer, pH 8.0, containing 4 mM deoxycholate 
and the same protease inhibitors as were used in the preparation of SEA. Approximately 
100,000 schistosomula per miiliter were kept in detergent solution on ice for 30 rain. 
Soluble schistosomula surface preparation was collected by centrifugation of the detergent 
extract at  15,000 g  for 60  min at 4°C.  The supernatant was collected and stored at 
-70°C. 
For Western blotting, antigen samples  were electrophoresed according to Laemmli 
(23).  At the completion of SDS-PAGE,  the proteins were transferred from the gels to 
nitrocellulose paper as described by Towbin et al. (26). After transfer, the nitrocellulose 
paper was quenched by incubation at room temperature for 1 h in PBS containing 0.30% 
Tween  20.  The  nitrocellulose strips  were  then  incubated  with anti-egg  monoclonal 
antibodies or control antibody (anti-Leishmania IgG2b provided by Dr. Diane McMahon 
Pratt, Harvard Medical School) overnight at 4°C. After this incubation, the strips were 
washed in PBS containing 0.05% Tween 20. Finally, the strips were incubated with a~5I- 
rabbit anti-mouse IgG, washed in PBS-Tween, dried, and exposed to x-ray film. 
Results 
Detection of Surface-Binding  Antibodies.  Anti-egg hybridoma culture  superna- 
tants  were  screened  by indirect immunofluorescence for surface-binding anti- 
bodies on living skin-stage schistosomula and isolated cercarial tails. Hybridomas 
yielding supernatants that were positive in the initial assay were cloned and then 
rescreened  for surface binding antibody.  Fig.  1 compares  the  surface-binding 
patterns  seen  on  skin-stage schistosomula  when  monoclonal antibody E. 1,  in- 
fected mouse serum, or normal mouse serum were examined. It can be seen that 
both_monoclonal antibody E. 1 and infected mouse serum bound uniformly to 
the surface of the schistosomular body. Although not shown in the photographs, 
E. 1 and chronic mouse serum also bound to cercarial tails. Infected mouse serum 
and the monoclonal antibody exhibited comparable levels of fluorescence inten- 
sity in  all  indirect  immunofluorescence assays performed.  All  surface-binding 
monoclonal antibodies produced using lymphocytes from mice immunized with 
whole  living  eggs  bound  to  both  schistosomular  bodies  and  cercarial  tails. 
Monoclonal antibodies generated from the fusion in which SEA was used for the 
final  boost  (see  Materials  and  Methods)  demonstrated  two  different surface- 
binding patterns: those which bound to the surface of schistosomular bodies and 
cercarial  tails,  such  as  E.1,  and  those  which  only  bound  to  the  surface  of 
schistosomula but not to cercarial tails. HARN,  MITSUYAMA, AND  DAVID  1375 
FIGURE  1.  (A, B, C) fluorescence patterns, (D, E, F) light microscope (A + D) normal mouse 
serum (B + E) monoclonal  antibody EG1C4BI, (C + F) infected mouse sera. 1376  SCHISTOSOMA  MANSONI  ANTI-EGG  MONOCLONAL  ANTIBODIES 
Persistance of Antigens  on Developing Schistosomula.  Studies were performed to 
assess how long after transformation of cercariae to schistosomula the monoclonal 
antibodies  could  still  detect  surface  antigens.  Skin-stage  schistosomula  were 
cultured as described for up to 96 h posttransformation, and, during this period, 
the parasites elongated and gut development occurred. 11 monoclonal antibodies 
were assayed for surface binding at 24, 48, and 96 h after transformation of the 
schistosomula. Table I lists the 11 monoclonal antibodies tested and the last time 
point at which uniform surface membrane binding was detectable.  Monoclonal 
antibody  E. 1  was  representative  of the  group  of monoclonal  antibodies  that 
bound to  96-h  schistosomula.  However, E. 1 did not bind  to freshly harvested 
lung worms or to lung worms that were cultured for 24-48 h after collection. 
Species Specificity Assay  with  E. 1.  To  see  if monoclonal  antibody  E. 1  could 
detect  antigen  on  other  species  of human  schistosomes  or  on  heterologous 
helminths,  we assayed  for  surface  binding  on  mechanical  schistosomula  of S. 
haematobium and S. japonicum and on microfilaria of Brugia malayi using indirect 
immunofluorescence. E. 1 bound to the schistosomula bodies and to the cercarial 
tails of both species of schistosomes. No detectable fluorescence was observed on 
the microfilaria.  The intensity of fluorescence was the same in S. mansoni and S. 
japonicum but lower on the S. haematobium organisms. 
In Vitro Complement-mediated Helminthotoxicity Using E. 1.  Monoclonal antibody 
E. 1 was used in these experiments because it detected antigen on the surface of 
developing schistosomula for at least 96 h posttransformation and was shown to 
be an IgG2b in the isotype ELISA.  Infected and normal mouse sera were used 
as positive and  negative controls.  Experiments  were done using fresh or heat- 
inactivated  guinea  pig serum  as  complement  source and  control.  Monoclonal 
antibody E. l, when incubated with fresh guinea pig serum,  caused tegumental 
blebbing and granulation  of parasites with 24 h  of incubation.  Control schisto- 
TABLE  I 
Persistance of Surface Membrane Antigens on Cultured Schistosomula 
Clone  Isotype 
Hours post- 
transformation 
that antigen is 
still detectable* 
EG 1C4B 1  G~b  96 
EG564C7  G2b  96 
EG2H5A9  Gs  96 
EG5H 1  G3  96 
SG1D12D8  M  96 
SGID12D10  M  96 
SGZ 1D4E5  M  96 
SG5E12.D11  M  48 
SG1D12.E12  A  48 
SG43B11E8  M  48 
SG5EI2.C8  M  24 
E  denotes monoclonals generated by  immunization with 
schistosome eggs. S denotes monoclonals generated from 
mice whose final boost was SEA. 
* Determined by indirect immunofluorescence on living par- 
asites. HARN,  MITSUYAMA,  AND  DAVID  1377 
somula cultured for the same period of time in normal mouse serum and fresh 
guinea pig serum appeared normal.  Fig.  2 demonstrates the contrast between 
parasites in normal mouse serum and complement and parasites in monoclonal 
antibody and  complement. The  maximal number of dead parasites,  as deter- 
FIGURE 2.  Complement-mediated damage to schistosomula.  (A) normal mouse sera  plus 
fresh guinea pig sera, (B) EG1C4BI plus fresh guinea pig sera. 1378  SCHISTOSOMA  MANSONI ANTI-EGG  MONOCLONAL  ANTIBODIES 
mined by dye uptake and loss of motility, was found on day 3.  The percentage 
of parasites killed by monoclonal antibody or infected mouse serum plus fresh 
guinea pig serum was similar,  65 and  73%, respectively, while only 2.4%  were 
killed when normal mouse serum was used (see Table II). In experiments where 
heat-inactivated  guinea  pig serum  was substituted  for fresh guinea pig serum, 
only 7.0 to 8.0% of the parasites were killed when coincubated with monoclonal 
antibody or infected mouse serum,  indicating  that parasite  killing was comple- 
ment dependent. 
In Vivo Passive Transfer of  Immunity: Lung Assay.  These experiments were done 
to  see  if  monoclonal  antibody  E. 1  could  alter  patterns  of invasion  and/or 
migration of larvae in vivo. In all of these experiments, monoclonal antibody or 
control sera were administered  to the mice at least  3 h  before challenge.  The 
delay of migration of parasites was measured by lung assay. Normal and infected 
mouse sera were used as controls. As is shown in Table III, monoclonal antibody 
E. !  was as effective or more effective than  infected mouse serum in  reducing 
the percentage of worms detected in the lungs on day 4  postchallenge.  In the 
TABLE  II 
Complement-mediated Damage/Killing of Skin Schistosomula Using 
Monoclonal Antibody EGIC4B1 
Guinea pig sera 
Percent of  Percent of 
schistosomula  schistosomula 
damaged* at  killed** at 
24 h  day 3 
Normal mouse serum  Fresh  2.5  2,4 
Heated  2.0  1.7 
Chronic sera (1 : 10)  Fresh  42.0  72,6 
Heated  9.9  7.8 
EGIC4B I  Fresh  33.3  64.8 
Heated  15.4  7.0 
* Membrane blebbing and granularity. 
* Determined by toluidine blue uptake/exclusion and nonmotility. 
TABLE  III 
Passive Transfer of Protection to Schistosoma Mansoni Using Monoclonal 
Antibody EG IC4B1 * 
Experi-  Mean number of  Percent 
ment  worms  protection 
1  Normal sera  44 +  15 
Chronic sera  16 +  11  66 
Monoclonal antibody  19 _  8  57 
2  Normal sera  40 ___ 20  -- 
Chronic sera  12 4- 9  70 
Monoclonal antibody  5 +  6  88 
3  Normal sera  63 4- 16  w 
Chronic sera  19 :t= 16  60 
Monoclonal antibody  16 4- 11  75 
* 500  mechanical somula injected intravenously.  Monoclonal antibody (culture superna- 
tant) given 3-12  h  earlier. Lung worms harvested on day 4. Experiments 2 and 3  used 
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three experiments shown, the reduction in the number of lung worms recover- 
able  on  day  4  ranged  from  57  to  88%.  The  reduction  was  maximum  in 
experiments 2 and 3, where five times concentrated culture supernatants were 
used as the source of monoclonal antibody. 
In Vivo Passive Transfer of Immunity: Adult Worm Assay.  To test the effects of 
monoclonal antibody E. 1 on natural infections in mice, we performed passive 
transfer of immunity experiments, assaying for surviving adult worms 6-8 wk 
postchallenge. The level of protection was based on the reduction in the number 
of surviving adult worms in mice given E. 1 as compared with mice given normal 
mouse serum or myeloma G2b.  In five of these experiments, mice were given 
varying amounts of monoclonal antibody to see if the protective effect of E. 1 
might be dose dependent. In one of these experiments, we also tested to see if 
antigen-binding Fab fragments could mediate an in vivo protective effect. Results 
from  these  five  separate  experiments  demonstrate  that  significant  levels  of 
protection were achieved even when extremely low levels of monoclonal antibody 
were  used.  Fig.  3  summarizes  five  experiments and  shows  that  the  level  of 
protection  was  apparently  dose  dependent  within  the  40-150  gg  range  of 
monoclonal antibody concentrations. Levels of protective immunity ranged from 
21% for 40 #g of antibody to 41% for 300 #g of antibody. Table IV shows the 
data for the experiment that gave a protective level of 41%.  It is also shown in 
Table  IV  that  antigen-binding  Fab  fragments  were  unable  to  mediate  any 
protective immunity, indicating that the Fc portion is probably important in such 
immunity. 
Analysis of the Molecular Weights of Antigens  Detected by Anti-Egg Monoclonal 
PASSIVE TRANSFER OF  IMMUNITY 
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FIGURE 3.  Passive transfer of immunity by  EG1C4BI.  Adult worm  assay.  Results of five 
different experiments using different amounts of monoclonal antibody are shown. The number 
of worms recovered from negative control mice for each experiment were as follows: 40 #g, 
67 +  9; 150 #g, 48 ±  9; 250 eg, 81 ±  7; 300 #g, 91 ±  5. 1380  SCHISTOSOMA MANSONI ANTI-EGG MONOCLONAL ANTIBODIES 
TABLE  IV 
In Vivo Passive Transfer of Protection by Purified Monoclonal Antibody 
EG1C4B1, But Not by Fab Fragment of EG1C4B I: Adult Worm Assay* 
Number of adult worms 
4- SEM  Percent protection 
Myeloma G2b  91.2 4- 4.6 (n = 9)  -- 
Purified EG1C4BI*  54.0 4- 6.5 (n = 9)  41 (P < 0.0002) 
FAB of EGIC4B10  97 + 6.0 (n = 6)  0 
Mice were challenged  with  180 cercariae per mouse by belly penetration. 
* Recovered 6 wk postinfection. 
* Protein A-Sepharose-purified; 150 #g was administered  at 25 and 5 h before challenge 
(300 ug/mouse total). 
0 Fab fragments of protein A-purified antibody administered  as above. 
FIGURE 4.  Western  blot analysis of egg antigens  detected  by monoclonal  antibodies.  (A) 
monoclonal antibody EG 1C4B 1  ; (B) monoclonal  antibody 5El 2:D 11, representative  of the 
48-h group of monoclonal antibodies;  (C) anti-Leishmania monoclonal antibody (IgG2b). 
Antibodies.  Anti-egg  monoclonal  antibodies  that  bound  to the  surface  of skin- 
stage  schistosomula  were  used  in  Western  blot analysis  to determine  molecular 
weights of the respective antigens.  As is shown in Fig.  4, two different molecular 
weight patterns were exhibited by anti-egg monoclonal antibodies binding to egg 
antigens.  Protective  monoclonal  E. 1  (Fig.  4A) is  representative  of the group of 
monoclonals that bind to 96-h schistosomula.  The  antigens detected  on eggs by 
these monoclonats are at approximate molecular weights of greater than 200,000, HARN,  MITSUYAMA,  AND  DAVID  1381 
200,000,  and  111,000.  Those monoclonal antibodies that bind to 48-h worms 
bind to the egg antigens shown in lane B.  In both cases,  the samples were not 
reduced. When comparing egg and schistosomular antigens recognized by E.1 
(Fig. 5), we noticed that the two antigens in the schistosomular preparation were 
of 160,000 and 130,000 molecular weight, different from those found in soluble 
egg antigen. 
Discussion 
The  data  presented  herein  show  that  monoclonal  antibodies  recognizing 
surface membrane antigens on schistosomula and/or cercariae can be produced 
from mice immunized with eggs. It is also shown that one anti-egg monoclonal 
antibody,  E. 1,  partially  protects naive mice from challenge with cercariae.  Al- 
though  other  workers  (5,  7-10)  have  tried  previously  to  induce  protective 
immunity by immunizing with eggs or egg extracts, such attempts have generally 
failed to generate resistance  to challenge infection.  On  the other hand, it has 
been  shown that  there are  many different egg antigens (27-29)  and that egg 
antigens elicit several types of immune reactions (30-32).  Significantly, eggs or 
egg  antigens  have  been  implicated  in  the  suppression  of  the  cell-mediated 
immune response (33-35). 
Our data, taken together with the results of these earlier studies, suggest the 
FIGURE 5.  Western blot comparing egg and schistosomula antigens recognized by monoclo- 
nal antibody  EG1C4B1.  (A  +  B)  SEA,  (C  +  D)  schistosomula surface extract,  (A  +  C) 
monoclonal antibody EGIC4B1, (B + D) anti-Leishmania monoclonal antibody (IgG2b). The 
minor band  (B)  200,000  tool wt,  seen by anti-Leiskmania  monoclonal antibody, has only 
appeared this one time. Five other blots all appear in Fig. 4. 1382  SCHISTOSOMA  MANSONI  ANTI-EGG  MONOCLONAL  ANTIBODIES 
possibility that the inability to demonstrate  protection in mice immunized  with 
eggs  or  complex  egg  extracts  results  from  suppression  of the  cell-mediated 
immune response, rather than the lack of protective antibody. We have demon- 
strated here, as have Lichtenberg et al. (8) and Bickle et al. (10) in earlier studies, 
that  immunization  with  eggs  gives  rise  to  antibodies  that  recognize  surface 
membrane epitopes on cercariae and schistosomula. Thus, if there is a suppressive 
response to avoid, it may be necessary to immunize  with only one or a  limited 
number of egg epitopes. Although several laboratories have reported the puri- 
fication  of different egg antigens  (36-39),  we know of no attempts  to induce 
protective immunity with them. 
However, we do know from results presented here that there are at least three 
egg antigens that cross-react with surface determinants on developing schistoso- 
mula. One of these antigens is putatively protective, and is present on the surface 
membranes of S. japonicum and S.  haematobium  as well as S.  mansoni.  The same 
antigen  has  also  been  shown  to  persist  on  developing  larvae  for  up  to  96  h 
posttransformation. 
The  observation  that  antigens  persist  on  developing larvae  is interesting  in 
light of the work by Samuelson et al. (40) and Dessein et al. (41). Both of those 
studies showed that a majority of the antigenic components on the early schisto- 
somulae were shed within the first 24 h  of culture.  In this study, we examined 
11  different anti-egg  monoclonal  antibodies and  detected three different time 
patterns of antigen  persistence.  However, both of the other studies used serum 
antibodies,  either  from  immunized  rats  or infected patients,  whereas we used 
monocional antibodies prepared  from mice immunized  with eggs or egg prod- 
ucts.  Since the  serum antibodies probably recognized several different surface 
antigens,  it is quite possible that  a  loss of one or more major surface antigens 
during development would dramatically lower the overall fluorescence intensity 
observed. 
In our experiments on protective immunity, we concentrated on a monoclonal 
antibody (E.1) that bound to the surface of developing larvae for at least 96 h 
posttransformation.  This monoclonal antibody, when injected intraperitoneally, 
markedly  diminished  the  number  of lung  worms  that  were recoverable.  The 
reduction in numbers of recoverable parasites was comparable to or better than 
that obtained when infected mouse serum was used. E. 1 was also very effective 
in reducing the adult worm burden.  The level of immunity in each experiment 
appeared to be related to the amount of monoclonal antibody administered. The 
upper  levels  of protection  are  comparable  or  higher  than  those  achieved  by 
Smith  et  al.  (42)  or  Zodda  and  Phillips  (43).  In  their  studies,  the  source  of 
monoclonal antibodies was ascites or serum.  In either case, the level of antibody 
administered in their experiments was probably much higher than that used in 
this study. 
In one passive transfer experiment, we found that purified Fab fragments were 
unable to reduce the adult worm burden  when  compared with purified  intact 
E. 1. Thus, the Fc portion of the monoclonal antibody was necessary for in vivo 
protection. Whether the intact antibody mediates protection in vivo via comple- 
ment or by antibody-dependent cellular cytotoxicity is not known. In our exper- 
iments, E. 1 was capable of killing parasites in vitro with complement; however, HARN,  MITSUYAMA, AND  DAVID  1383 
Sher et al. (44) have demonstrated that complement-depleted mice do not show 
diminished levels of resistance to challenge in vivo. 
Although protective monoclonal antibodies to S. mansoni have been produced 
by Smith et al.  (42),  Zodda and  Phillips (43),  and Grzych et al.  (45),  only the 
latter two groups have been able to use the monoclonal antibodies to characterize 
the relevant antigens by immunoprecipitation. The antigen detected by E.1  is 
different in molecular weight from the antigen described by Dissous et al. (46). 
The molecular weight of our antigen is similar to that of the antigen described 
by  Zodda  and  Phillips  (43),  but  in  side  by  side  Western  blot  experiments 
performed at the Schistosome Antigen Workshop (47),  their monoclonal anti- 
body did not bind to the same antigen preparations as did E. 1. 
Surface  antigens  recognized  by  monoclonal antibodies  produced by  others 
(48-50)  are  also  probably  different  from  the  antigen  detected  by  E.1.  The 
surface antigen reported by Taylor and Butterworth (48) is different in molecular 
weight from that detected by E. 1.  Though the molecular weights of antigens 
reported by Norden et al. (49) and Aronstein et al. (50) are similar to that of the 
antigen detected by E. 1, their monoclonal antibodies differ in that they do not 
bind to eggs (49) or to cercariae (50). 
Although our results suggest that egg antigens may be important in inducing 
naturally acquired resistance, it is of note that effective protective immunity can 
also be induced by irradiated cercariae that do not produce eggs (51, 52). 
The  finding  that  an  anti-egg  monoclonal  antibody  is  partially  protective 
suggests the possible use of egg antigens that cross-react with schistosomula for 
vaccination  studies.  It  must  be  considered,  however,  that  egg  antigens  can 
sensitize for granuloma formation (26). However, studies by Warren and Dom- 
ingo (53) have shown that immunization with cercariae, unisexual infections, or 
dead worms do not sensitize for granuloma formation. Because our protective 
antigen cross-reacts with epitopes on larval stages, it also is likely not to sensitize 
for granuloma formation, although this must be tested. 
The data presented in this paper suggest that if naturally acquired immunity 
to schistosomes is dependent on the production of eggs, the function of the egg 
in protection may not be totally nonspecific. The results clearly show that eggs 
and egg antigens elicit the production of antibodies that cross-react with mem- 
brane antigens on invading larval stages and that can mediate protective immu- 
nity. 
Summary 
Monoclonal antibodies that bind to surface membranes of developing schisto- 
somula and/or cercarial tails were generated from mice immunized with living 
schistosome eggs or soluble egg antigen. These monoclonal antibodies detected 
at least three different surface epitopes. One surface antigen detected by anti- 
egg monoclonal antibody EG 1C4B 1 (E. 1) persisted on the surface of developing 
schistosomula for 96 h posttransformation. The same or a cross-reactive antigen 
was also detected on the surfaces ofS. japonicum and S. haematobium schistosomula 
and cercarial tails. Monocional antibody E. 1 killed schistosomula in vitro as well 
or better than infected mouse sera and transferred immunity to naive mice when 
administered in  vivo.  The monoclonal antibody reduced the  number of lung 1384  SCHISTOSOMA  MANSONI ANTI-EGG MONOCLONAL ANTIBODIES 
worms recoverable on day 4 postchallenge by up to 85% and reduced the adult 
worm burden up to 41% as compared with controls. The data also show that the 
molecular weights of the egg antigens detected by monoclonal antibody E. 1 were 
different from those detected on schistosomula. 
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